SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders discuss potential U.S.-China trade deal impacts and the strength of big tech companies like Apple, with community members weighing in on bullish and bearish signals. Debate centers around whether recent market behavior is indicative of a healthy consolidation or a looming correction, with some expressing concerns about potential risks in AI and regional banks. News of potential interest rate cuts, rising treasury yields, and key economic data releases are adding to the conversation.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as the community discusses its recent price surge and potential for further gains, with some targeting prices such as $300 and beyond. Privacy narratives and comparisons to Bitcoin are circulating, while others speculate on market manipulation and future price corrections. Discussions also include the upcoming 9 year anniversary.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SUGP is trending as traders discuss its low float and potential for a short squeeze, drawing comparisons to other Hong Kong-based stocks that have recently seen significant gains. The community is also highlighting the company's regained NASDAQ compliance and a new contract exceeding its market cap, with some speculating on a potential short squeeze due to the high cost to borrow. Positive sentiment is further fueled by SUGP's expansion into EV infrastructure and AI-powered solutions.

Fuzzybear ($FUZZY) is a memecoin on the XRP Ledger (XRPL), created to honor the legacy of the well-known XRPL address ‘Fuzzybear,’ which famously placed a DEX order in 2014: 1 XRP for 1 BTC. The token embodies the spirit of decentralization and community-driven growth, focusing on fun, engagement, and organic expansion. With its unique narrative and strong community, Fuzzybear grows naturally as more supporters join the movement.

Fuzzybear

Fuzzybear ($FUZZY) is trending as community members highlight its connection to XRP and potential role within the XRP Ledger ecosystem, with some suggesting it could be the next big memecoin. Discussions also mention an upcoming event and the potential for exchange listings, fueling speculation and interest. Community members also note that David Schwartz, Ripple's CTO, recently joined a discussion about Fuzzybear on X.

Towns

$TOWNS is trending as community members actively discuss recent price movements and encourage others to join. Some users highlight potential for significant gains, while others speculate about exchange listings and future developments. The community references other trending tickers and possible connections to external entities, contributing to the heightened interest.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors discuss the potential of ivonescimab, particularly following trial data suggesting reduced cancer progression risk; the community is analyzing the drug's efficacy and overall survival benefits, while also considering potential regulatory hurdles and competition in the oncology market. Some traders point to insider buying as a bullish signal, while others express caution regarding the drug's performance in specific patient groups and the company's overall valuation. The conversation also includes speculation about potential partnerships and upcoming presentations of trial data.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the crypto community debates its next move, with attention focused on key resistance levels and potential pullbacks. Bullish sentiment revolves around institutional accumulation and the possibility of a supply squeeze, while bears cite technical indicators and historical patterns suggesting a correction. Discussions also include the influence of macroeconomic factors and potential regulatory developments.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is garnering attention as community members discuss its potential, partnerships, and valuation relative to competitors like Progressive. Conversations revolve around whether the company can translate partnerships into substantial growth and if upcoming earnings will reflect this. Despite recent price declines, some investors remain optimistic, viewing it as an undervalued opportunity with long-term potential akin to early-stage Tesla or Hood.

SSgA Active Trust - Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

The technology sector, represented by XLK, is seeing mixed signals with potential tariff implications and leadership shifts impacting market sentiment. Community discussions revolve around whether current levels can be sustained, and if a broader market pullback is on the horizon, especially given earnings results from major tech companies and conflicting reports regarding trade policies. Despite some analysts remaining bullish, concerns about the sector's future performance are being actively discussed.

What is Tron? Tron's mission is to build a truly decentralized internet and aims to be the largest blockchain-based operating system in the world, known as the TRON protocol. The TRON protocol will offer high scalability, high availability, and high throughput computing to serve decentralized applications via smart contracts. Ethereum EVM-based smart contracts will be compatible and deployable on the TRON network as such Solidity developers do not have to rewrite their applications.  Why Tron? Since TRON protocol does not rely on proof of work or mining, instead governed by nodes located around the world, it is decentralized while providing high throughput for transactions on the blockchain. This is suitable for dapps that require high speed transactions especially games. There are a number of tokens already issued on the TRON network and the decentralized exchanges TRX.market has launched.  On July 24th 2018, TRON acquired BitTorrent, one of the largest P2P file sharing protocol. As a result of the acquisition, BitTorrent Token (BTT) was launched as the cryptocurrency to power the economics on the BitTorrent network. The Token will be used to inceltivize file sharing and storage within the network.

Tron

Tron is trending as the community discusses its strong ties to Rumble and Tether, including cloud deals and potential for Rumble's crypto wallet, and some users speculate about a partnership with MoonPay. Some are noting $TRX's stability compared to other cryptos. Chatter also includes discussion on the upcoming Tron Ares movie.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OMCL or HIMS: Which Is the Better Value Stock Right Now?

OMCL vs. HIMS: Which Stock Is the Better Value Option?

Hims &amp; Hers Health Inc. (HIMS) stock came under the spotlight on Friday after the company stated in a U.S. Securities and Exchange Commission (SEC) filing that CEO Andrew Dudum had pared his stake in the telehealth company.According to an SEC filing on Thursday, Dudum sold 175,661 shares of the company for an aggregate value of about $11 million. The share sale comes a day after the company’s new menopause and perimenopause service launch.The company officially&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/hims-and-hers-stock-notches-best-day-in-3-months-after-bof-a-s-bullish-call-on-menopause-launch/ch6YnvIR3VE">launched</a> the service on Wednesday, providing women with access to tailored treatment plans for symptoms like hot flashes, mood changes, and sleep issues via its digital platform.Hims &amp; Hers’ shares were down more than 12% in Friday morning’s trade. The HIMS stock was the top trending equity ticker on Stocktwits at the time of writing. Despite Friday’s decline, retail sentiment around the stock remained in ‘bullish’ territory amid ‘extremely high’ message volume levels.According to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/health/pharma/novo-nordisk-shares-fall-as-trump-moves-to-cut-price-of-weight-loss-drugs-22b479a9">report</a> by The Wall Street Journal, President Trump announced plans to push for a price reduction of Novo Nordisk’s Ozempic treatment in the U.S. The administration has been in price talks with several drugmakers, and negotiations with Novo Nordisk are still ongoing. Trump suggested that the drug’s cost could be reduced to around $150.The company is scheduled to report its third-quarter earnings on November 3. It expects Q3 revenue in the range of $570 million to $590 million and an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in the range of $60 million to $70 million.&nbsp;Hims &amp; Hers Health stock has gained over 112% year-to-date and over 138% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/datadog-draws-wall-street-praise-ahead-of-q3-earnings/ch6sQbqR38V">Datadog Draws Wall Street’s Praise Ahead Of Q3 Earnings</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Hims & Hers Health logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Why Is Hims & Hers Health Stock Down 12% Today?

According to a SEC filing on Thursday, CEO Andrew Dudum sold 175,661 shares of the company for an aggregate value of about $11 million. 

Equity

According to a SEC filing on Thursday, CEO Andrew Dudum sold 175,661 shares of the company for an aggregate value of about $11 million. 


Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market

Hims & Hers Health, Inc. (HIMS) reached $59.15 at the closing of the latest trading day, reflecting a -5.75% change compared to its last close.

Hims & Hers Elevates Technology-Driven Healthcare Accessibility

HIMS boosts AI-led care with new technology chief, hormone therapies and a global push via its ZAVA acquisition.

Hims &amp; Hers Health shares logged their best session in almost three months on Wednesday after Bank of America’s research arm said the company’s new menopause and perimenopause service could open up a large new growth avenue for its Hers brand.The stock jumped 16.2% to close at $62.76 on Wednesday, before easing 2.2% in after-hours trading.BofA noted that the launch broadens Hims &amp; Hers’ reach into a multi-billion-dollar market and supports revenue diversification at a time when the men’s segment faces some pressure.&nbsp;The brokerage said the service, which offers personalized plans including hormone replacement therapies such as estradiol and progesterone, should make a modest financial contribution in the fourth quarter (Q4) before ramping into 2026. BofA maintained an ‘Underperform’ rating and a $28 price target on the stock.The company officially launched the service on Wednesday, providing women with access to tailored treatment plans for symptoms like hot flashes, mood changes, and sleep issues via its digital platform. The company’s Hers division, which focuses on women’s health, now serves more than half a million subscribers and aims to surpass $1 billion in annual revenue by 2026.“Women have been navigating an outdated healthcare system that wasn’t designed for them for too long. Hers was built to serve every woman on her terms,” said Jessica Shepherd, Chief Medical Officer of Hers. For eligible customers, personalized care may include prescription hormone therapies delivered in pill, patch, or cream form, overseen by licensed providers trained in menopause and perimenopause care.On Stocktwits, retail sentiment for Hims &amp; Hers was ‘extremely bullish’ amid a 934% surge in 24-hour message volume.One bullish user called Hims &amp; Hers the “best swing trade stock of 2025,” saying they’ve made consistent gains on its volatility and believe the stock could be starting a major run toward $100.&nbsp;<stembedurl>https://stocktwits.com/Chris0909/message/632499843</stembedurl>Another bullish user noted the breakout came on heavy volume and said a move toward $70 now looks likely.<stembedurl>https://stocktwits.com/ChronoSpider/message/632493129</stembedurl><a href="https://stocktwits.com/symbol/HIMS">Hims &amp; Hers’ stock</a> has surged 160% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Hims & Hers Health, Inc. is displayed on a smartphone screen on May 04, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

Hims & Hers Stock Notches Best Day In 3 Months After BofA’s Bullish Call On Menopause Launch: Retail Hails Year’s ‘Best Swing Trade Stock’

The rally followed BofA Securities’ announcement that the new menopause and perimenopause service represents a multi-billion-dollar market opportunity for HIMS, supporting revenue diversification. 

Hims &amp; Hers Health Inc. (HIMS) on Wednesday announced new specialty care options for menopause and perimenopause, in what it sees as a gap in health care access for women.The telehealth company stated that women can coordinate with a provider on its platform to access treatment plans that are tailored to their health history and preferences. “Women will spend an average of nine years in poor health, which is 25% more than men, and can impact their ability to be present at work, at home, and in their communities,” Hims &amp; Hers Health stated in its announcement.The company added that there are 1.3 million women in the U.S. who experience menopause each year, but that only 30% of Obstetrician-Gynecologist residency programs offer formal menopause training. This leaves the company with a wide addressable market, and Hims &amp; Hers sees this as an opportunity to help the Hers unit reach $1 billion in annual revenue in 2026.“Women have been navigating an outdated healthcare system that wasn’t designed for them for too long. Hers was built to serve every woman on her terms,” said Dr. Jessica Shepherd, Chief Medical Officer of Hers.<a href="https://stocktwits.com/symbol/HIMS">Hims &amp; Hers’ shares</a> were up more than 2% in Wednesday’s pre-market trade. Retail sentiment on Stocktwits around the company trended in the ‘bearish’ territory.The company stated that for eligible customers, personalized menopause and perimenopause treatment plans may include prescription medication in pill, patch, or cream forms. Hormone treatments for eligible customers may include estradiol to help alleviate hot flashes and night sweats, and progesterone, which helps protect the uterine lining and improve sleep quality.This comes a month after Hims &amp; Hers announced hormonal treatments in its men’s business, offering treatment plans for low testosterone.<a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> is up 123% year-to-date and 164% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/scott-bessent-china-us-trade-war-rare-earth-export-controls/ch6nxeJR3Nj">Scott Bessent Says US Has ‘Things That Are More Powerful’ Than China’s Rare Earth Export Controls: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hims & Hers Health Brings Menopause, Perimenopause Treatments On Its Platform

The telehealth company stated that women can coordinate with a provider on its platform to access treatment plans that are tailored to their health history and preferences.

Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new specialty in womens health, offering access to affordable treatment plans built...

Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell?

HIMS expands into men's health and hormones, but rising costs and regulatory hurdles threaten its momentum.

Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025

Hims & Hers Health, Inc. (Hims & Hers, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2025 financial results after the market closes on...

Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know

Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $53.96, signifying a -7.36% move from its prior day's close.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

HIMS
Hims & Hers Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HIMS News

HIMSHims & Hers Health Inc